Stay updated on Fisogatinib in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Expanded the study's Locations with new sites across the United States and China and removed several earlier location groupings; a revision tag (Revision: v3.3.3) was added.
    Difference
    2%
    Check dated 2025-12-23T09:01:04.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing the previous Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:54:49.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.1, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T13:36:03.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The Tainan City, Taiwan, 704 entry was updated to Tainan, Taiwan, 704 in the study locations.
    Difference
    0.3%
    Check dated 2025-11-17T06:29:11.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The two screenshots depict the same study page with no changes to core content such as eligibility criteria, outcomes, or locations; only minor UI/formatting tweaks are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:12:54.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    4%
    Check dated 2025-10-05T10:14:45.000Z thumbnail image

Stay in the know with updates to Fisogatinib in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.